Tag Archive: National Institute for Health and Care Excellence (NICE)

Oct 25

An independent appraisal committee for the UK’s National Institute for Health and Care Excellence (NICE)

An independent appraisal committee for the UK’s National Institute for Health and Care Excellence (NICE) is supporting the use of rivaroxaban as part of a secondary-prevention strategy in acute coronary syndrome (ACS) patients. The NICE appraisal committee states that rivaroxaban 2.5 mg twice daily with aspirin alone or aspirin plus clopidogrel or ticlopidine is an …

Continue reading »

Jul 19

The National Institute for Health and Care Excellence (NICE)

The National Institute for Health and Care Excellence (NICE) has published its new recommendations for the treatment of patients at risk for cardiovascular disease. The new NICE guidelines recommend that physicians initiate treatment with atorvastatin 20 mg in patients with a 10–year risk of cardiovascular disease that exceeds 10%.